Skip to content

Hanna Rodriguez Coleman, M.D.

Hanna Rodriguez Coleman

National Eye Health Education Program Spokesperson
National Eye Institute (NEI),
National Institutes of Health

Assistant Clinical Professor
New York Presbyterian Hospital - Columbia, New York

Representative and senior consultant
Digital Angiography Reading Center, New York, New York


  • Ophthalmology
  • Retinal diseases
  • Diabetic macular edema
  • Age-related macular degeneration

Current activities

Dr. Coleman is fluent in English and Spanish. She is currently an assistant clinical professor at New York Presbyterian Hospital and a senior consultant for the interpretation of Fluorescein and indocyanine green angiograms at the Digital Angiography Reading Center in New York. Dr. Coleman is a member of the American Academy of Ophthalmology, New York State Ophthalmological Society, and the American Medical Association.


Dr. Coleman is the author of more than 25 research articles based on her studies and published in the American Journal of Ophthalmology, Archives of Ophthalmology, The Lancet, Ophthalmology, Proceedings of the National Academy of Sciences, and Retina.

Research highlights

Dr. Coleman has served as Principal Investigator for several NEI studies including:

  • Pilot study of Intravitreal Injection of Triamcinolone Acetonide Formulation for Retinal Vascular Disorders (TACPF)
  • Phase III, multicenter trial - Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE)
  • Phase II/III, multicenter randomized clinical trial to study the effects of preservative-free triamcinolone acetonide as an Adjunct to Photodynamic therapy in Participants with Neovascular Age-related Macular Degeneration (VERTACL)
  • Phase I study of Intravitreal Injections Versus Anterior Sub-tenon Injections of Triamcinolone Acetonide Formulation for Macular Edema in Retinal Disorders (EXTAC)


National Eye Institute
(301) 496-5248
National Eye Institute

The National Eye Institute (NEI), part of the National Institutes of Health, leads the federal government's research on the visual system and eye diseases. NEI supports basic and clinical science programs that result in the development of sight-saving treatments.

Last updated: July 18, 2019